Metabolic inhibitors and viral lymphomagenesis in thymic grafts.
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D003561:Cytarabine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D005260:Female; D007109:Immunity / Q000528:radiation effects; D009052:Leukemia Virus, Murine; D008223:Lymphoma / Q000517:prevention & control*; D008297:Male; D051379:Mice; D011691:Puromycin / Q000494:pharmacology; D012038:Regeneration / Q000187:drug effects; D012293:Rifampin / Q000494:pharmacology; D013308:Streptonigrin / Q000494:pharmacology; D013310:Streptovaricin / Q000494:pharmacology; D013934:Thymectomy; D013950:Thymus Gland / Q000187:drug effects* / Q000276:immunology / Q000382:microbiology
D000963:Antimetabolites; D003561:Cytarabine; D013310:Streptovaricin; D003609:Dactinomycin; D013308:Streptonigrin; D011691:Puromycin; D012293:Rifampin